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feature of stimuli that initiate sensitization as opposed to continuous exposures that initiate tolerance (4) . Pharmacologic agents, direct electrical stimulation, and physical and psychological stressors can all initiate or elicit the amplified responses in TDS (2, 5, 6, 7) . Sensitization can interact with tolerance and with conditioning (8) (9) (10) , but each of these processes can be distinguished from the other by proper experimental design (8) (9) (10) . The mechanisms of sensitization are not fully understood but may involve persistent changes in neurotransmitters, receptors, and basic neural cellular functions (5, 6) . Sensitization of immune function can occur during TDS protocols (11) , but neural rather than classical immunological changes appear to mediate TDS of neurobehavioral functions (2, 6, 12) . For example, various investigators have blocked drug-induced sensitization in the central nervous system using excitatory amino acid antagonists (13) , nitric oxide synthase inhibitors (14) , protein synthesis inhibitors (15) , or delta-opioid receptor antagonists (16) . In TDS, the subcortical, dopaminergic mesolimbic pathways also may be involved (5, 6) . A special type of neural sensitization is kindling, in which periodic repeated electrical or chemical stimulation of brain limbic structures such as the olfactory bulb, amygdala, and areas of the hippocampus leads to permanent susceptibility to convulsions not seen upon initial stimulation (17) (18) (19) (20) (21) (22) .
Because most persons with multiple chemical sensitivity (MCS) do not have clinical seizure disorders, kindling per se is not the most apt model for their condition (7) . However, nonconvulsive TDS, subconvulsive kindling and/or related neural sensitization processes (7, 18, (20) (21) (22) (23) could provide an explanation for a puzzling feature of MCS, i.e., susceptibility to low levels of environmental chemicals that according to classical toxicological dose-response relationships should not occur (24) . Convergent lines of evidence point to this possibility. First , a subset, though not all, of MCS patients has been found to have increased lifetime histories or comorbid histories of certain psychiatric disorders, specifically major depression, anxiety disorders, and somatoform disorders (25) (26) (27) (28) (29) . Researchers in biological psychiatry have proposed for many years that the recurrent, long-term course of these conditions follows the pattern of a sensitized response in that progressively less severe life stress no stress at all is required to trigger later episodes of illness (12, 30) . Still others have reported increased histories of childhood abuse in certain MCS patients (31) . Early abuse may trigger increased rates of posttraumatic stress disorder (PTSD) (32, 33) . PTSD is a condition of persistent hyperreactivity to salient stimuli and other environmental stimuli (e.g., startle to noise) for which TDS is a leading model (2, 34) . Rather than assume that MCS is merely a misattribution of psychiatric symptoms from those conditions, an alternative view would be that the psychiatric findings and the MCS are both the result of an increased susceptibility to sensitization (7, 22) .
The second line of evidence that could provide an explanation for some patients' susceptibility to low levels of environmental chemicals is that other characteristics of TDS and MCS overlap (3, 5, 7, 22, (35) (36) (37) . For example, females are more susceptible to both TDS and MCS (38) . Both processes can be initiated by a wide range of chemically unrelated agents (3). Agents of different types can cross-sensitize with one another (2, 3, 5) . Elicited responses can proceed in a bidirectional manner (39, 40) . The amplified responses can occur in multiple different bodily systems (2, 3, 5, 17 (8, 43 ). An important implication of the latter points is that it will be essential to perform multiple, not one, exposure sessions separated in time to test the sensitization model for MCS (7, 22, 36) . That is, it is necessary to initiate and elicit sensitization within the same experiment (42 (46, 52) .
One potentially important set of subtyping questions would be about past and/or current history of certain psychiatric disorders (51) (42, 68, 69) . The ability to detect significant group differences in these between-group studies with these small samples suggests large estimated effect sizes. Similarly, animal studies of chemical sensitization with behavioral end points have used 9 to 32 animals per group (5, 20, 70) . A between-subjects design in human studies could risk Type II error from insufficient sample size and too low power to detect medium-or small-sized effects. Nonetheless, the high likelihood of carryover effects from one exposure condition to another in a within-subjects design favors using a between-subjects approach. If within-subjects designs are used, a counterbalanced order of exposure conditions in separate subgroups of each group, e.g., MCS and controls, would assist in clarifying any such asymmetric transfer of effects (71) . It will be necessary to restrict the number of outcome measures in any given protocol to limit confounding of results of one outcome measure by a preceding outcome measure (72) .
An additional consideration for experimental design is that of stimulus range effects (73) . The range of stimuli or the range of responses used by the subjects may affect their responses (73) . That is, sensitization studies within subjects would risk confounding by range effects if a given subject were to undergo more than one experimental condition. This problem again favors the use of separate groups for each concentration, stressor, and time factor. The nature of sensitization studies requires use of repeated sessions with the same outcome measure(s) in the same subjects, but the experimental condition (i.e., chemical vs sham exposures) and the timing of exposures must differ among subgroups of each group. Taken together, these issues point to the need for a large number of separate groups in human or animal sensitization studies to be certain of the source of a given finding. For example, Antelman et al. (74) used nine separate groups rather than the same group of animals (n = 6-10 per group) to evaluate the effects on mesolimbic dopamine status of pretreatment with a range of different intensity environmental stressors (home cage, clean cage, dirty cage, black box) interacting with a range of drug treatment conditions (no injection, saline injection alone, or 0.2 mg/kg haloperidol in saline given at three different time lags after the pretreatment: none, 2 hr, or 2 weeks). They also used entirely separate groups of animals to confirm the stressfulness of each of the pretreatment conditions with glucocorticoid measurements. It also may be necessary to consider similar separate studies and between-groups methodology in human sensitization studies (71) (72) (73) .
Experimental Conditions
Among many potential issues in the design of human MCS/sensitization studies are the following: state of adaptation or deadaptation of subjects (24) Related to the second issue, route of sensitization, laboratory sensitization in animals has been initiated primarily by injection with drugs or pesticides (3) (4) (5) (6) 19, 20) and inhalation with solvents such as toluene (21, 70) . In human studies, oral alcohol ingestion has been used successfully to initiate and demonstrate autonomic nervous system sensitization of nonalcoholics without first withdrawing them from alcohol outside the laboratory (42 (24) . In view of the animal evidence that a high estrogen-toprogesterone ratio might favor sensitization in females (93) and that testosterone might lessen sensitization in males (94) , an adjunctive exploratory measure for risk of sensitization in this human study might be blood levels of estrogen and progesterone at specified times in the menstrual cycle as well as blood levels of testosterone.
From the above list of possible dependent variables, an initial selection might include physiological measures considered most likely to detect group differences, i.e., stabilometer (general motor activity level), respiration, heart rate, pupil, EEG and cognitive event-related potentials (auditory odd-ball paradigm), and facial EMG (an objective and sensitive correlate of mood state). For mood changes and cognitive dysfunction respectively, the POMS and specific neuropsychological tests previously found to show differences from those of controls in studies of chemically intolerant or solvent-exposed persons (e.g., divided attention, continuous performance test) would be appropriate (85, 89, 95) .
All participants would undergo initial baseline sessions on filtered room air delivered by an olfactometer similar to that used by Kobal and Hummel (83) to facilitate habituation to the novelty of the laboratory and procedures. For subsequent sessions in this study, an olfactometer would deliver brief exposures to filtered room air (the placebo) and test chemicals (e.g., subolfactory and supraolfactory threshold levels of toluene in air stream) (below and above threshold). Half the participants in each group would get filtered room air during the entire experiment and half of each group would get the chemical (split-plot design). The exposure would occur as either intermittent bursts (1-min exposure, 3-min wait) or continuous exposures for at least 10 to 15 min. Additional sessions would occur at 1-, 2-, and 3-week intervals at the same time of day.
While studies designed to elicit acute adverse reactions in MCS patients raise ethical concerns, the need for systematic understanding of this illness and its mechanisms is pressing. Lack of data has severely hampered research on possible preventive and treatment interventions. At the present stage of knowledge about MCS, the potential benefits outweigh the risks. That is, acute reactions in chemically sensitive individuals typically resolve within minutes to hours after conclusion of a low-level chemical exposure. Most patients do not experience life-threatening symptoms during such reactions, and those with disorders such as asthma or epilepsy can be screened out of the studies. However, even in standard clinical practice, diagnostic testing for conditions with episodic rather than continuous clinical manifestations, e.g., methacholine challenge in asthma or hyperventilation during EEG recording in epilepsy, often involves deliberate provocation of acute exacerbations as part of a workup. The laboratory context-dependent design of the present proposed experiments would minimize the risk of persistent worsening of a patient's long-term course, as discussed above. Thus, it is reasonable to proceed with acute chemical exposure research in MCS at this time. The emergence of new data in the area may or may not necessitate reassessment of the ethics of additional challenge studies in the future.
Experiment 2, Longitudinal Study
In addition to acute studies, longitudinal studies with repeated measures would permit evaluation of fluctuations over time in MCS, which is inherently a chronic condition (48 (21, (96) (97) (98) . Although inhalation exposures through the lung obviously occur simultaneously with olfactory system stimulation, and although the inhalation route may play some role in modulation of neural sensitization, the concentration of inhaled chemicals reaching the brain from nonolfactory routes of administration probably is not sufficient to cause the kinds of neural activation necessary to support a kindlinglike process (98) . Accordingly, although bloodborne chemical contaminants may contribute to some systemic chemical kindlinglike effect, if a neural sensitization process is involved in the development of MCS, it is more probable that the process involves the output from stimulation of the olfactory apparatus (96) (97) (98) (99) (100) (101) .
Olfactory pathways, specifically the olfactory bulbs, are particularly sensitive to electrical and chemical kindling (21) . Additionally, the receptors in the olfactory epithelium form a direct access pathway to limbic structures in the central nervous system. It is reasonable, therefore, to assume that strong activation of the olfactory epithelium cells can provide sufficient input into CNS limbic circuits to induce sensitization. It probably is possible to design studies that indirectly test this hypothesis using human subjects, but the specific role of olfactory stimulation in the ontogeny of MCS can be directly evaluated using standard neurophysiological assessments of central olfactory and limbic structures in response to stimulation of the olfactory epithelia of laboratory animals (21 (61, 64, 65) and active community elderly (62, 63) as well as by 30% of office workers (67) and of a rural communitybased population (66) , merits systematic investigation of its phenomenology, course, and possible mechanisms.
